|
AU2012201010A1
|
|
Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
|
|
US2011082083A1
|
|
Formulations of liquid stable antithrombin
|
|
EP2279003A2
|
|
An anti-cd137 antibody as an agent in the treatment of inflammatory conditions
|
|
AU2007205719A1
|
|
Transgenic production of antibodies in milk
|
|
WO2007124019A2
|
|
Methods and products related to the transfer of molecules from blood to the mammary gland
|
|
WO2008100258A1
|
|
Intraperitoneal administration of antithrombin iii, related compositions and methods
|
|
KR20080068089A
|
|
Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use
|
|
US2007037192A1
|
|
Method of purifying recombinant human antithrombin to enhance the viral and prion safety profile
|
|
WO2006138647A2
|
|
Method of making recombinant human antibodies for use in biosensor technology
|
|
US2008004212A1
|
|
Methods of reducing the incidence of rejection in tissue transplantation through the use of recombinant human antithrombin
|
|
US2006191029A1
|
|
Method and system for fusion and activation following nuclear transfer in reconstructed embryos
|
|
US2006179500A1
|
|
Methods and vectors for improving nucleic acid expression
|
|
US2007192878A1
|
|
Clarification of transgenic milk using depth filtration
|
|
WO2007001264A2
|
|
Method of making recombinant human antibodies for use in biosensor technology
|
|
WO2006062543A1
|
|
A method of purifying recombinant msp 1-42 derived from plasmodium falciparum
|
|
WO2006078262A2
|
|
Methods of activation during nuclear transfer
|
|
US2006123500A1
|
|
Methods of prescreening cells for nuclear transfer procedures
|
|
EP1850872A2
|
|
A method of using an anti-cd137 antibody as an agent for radioimmunotherapy or radioimmunodetection
|
|
WO2005079525A2
|
|
A method for the production of transgenic proteins useful in the treatment of obesity and diabetes
|
|
KR20100017971A
|
|
Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
|
